ACE Inhibitors
Sponsors
NYU Langone Health, Johns Hopkins University, GlaxoSmithKline, Tel-Aviv Sourasky Medical Center, Ain Shams University
Conditions
AtherosclerosisCardiotoxicityCardiovascular DiseasesCerebral ArteriosclerosisCoronary DiseaseDiabetes MellitusHeart DiseasesHeart Failure
Phase 3
Phase 4
Reducing Total Cardiovascular Risk in an Urban Community
CompletedNCT00241904
Start: 2006-05-31End: 2010-05-31Updated: 2017-09-15
Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)
CompletedNCT00344513
Start: 2002-12-16End: 2005-06-30Target: 50000Updated: 2020-11-24